Existing reviews on IBD biomarkers have primarily focused on conventional markers such as fecal calprotectin or C-reactive protein and have not quantitatively evaluated chemerin’s diagnostic or activity-monitoring value [31, 32]. The gene discussed is RARRES2; the disease is inflammatory bowel disease.